ACP Guideline Finds No Substantial Differences Among "Second ...
****************************** (Austria) To develop the guideline, ACP reviewed more than more than 200 published studies about the benefits and harms of second-generation drugs " bupropion, citalopram, duloxetine, escitalopram, fluoxetine, fluvoxamine, mirtazapine, nefazodone, paroxetine, sertraline, trazadone, and venlafaxine " used to treat depression. (Mon Nov 17 17:50:42 2008 PST)
[also ibtimes12326, eurekalert.org5664]